TFBS Bioscience Inc. (6939.TWO)

TWD 32.3

(1.1%)

Long Term Debt Summary of TFBS Bioscience Inc.

  • TFBS Bioscience Inc.'s latest annual long term debt in 2023 was 101.84 Million TWD , up 355.2% from previous year.
  • TFBS Bioscience Inc.'s latest quarterly long term debt in 2023 FY was 101.84 Million TWD , up 355.2% from previous quarter.
  • TFBS Bioscience Inc. reported annual long term debt of 22.37 Million TWD in 2022, up 39.99% from previous year.
  • TFBS Bioscience Inc. reported annual long term debt of 15.98 Million TWD in 2021, up 16.13% from previous year.
  • TFBS Bioscience Inc. reported quarterly long term debt of 101.84 Million TWD for 2023 Q4, up 479.58% from previous quarter.
  • TFBS Bioscience Inc. reported quarterly long term debt of 17.57 Million TWD for 2023 Q2, down -21.46% from previous quarter.

Annual Long Term Debt Chart of TFBS Bioscience Inc. (2023 - 2020)

Historical Annual Long Term Debt of TFBS Bioscience Inc. (2023 - 2020)

Year Long Term Debt Long Term Debt Growth
2023 101.84 Million TWD 355.2%
2022 22.37 Million TWD 39.99%
2021 15.98 Million TWD 16.13%
2020 13.76 Million TWD 0.0%

Peer Long Term Debt Comparison of TFBS Bioscience Inc.

Name Long Term Debt Long Term Debt Difference
BIONET Corp. 6.03 Million TWD -1587.26%
DIVA Laboratories, Ltd. - TWD -Infinity%
Genetics Generation Advancement Corp. 10.34 Million TWD -884.466%
Welgene Biotech Co.,Ltd. 118.97 Million TWD 14.397%
Puriblood Medical Co., Ltd. 43.7 Million TWD -133.045%